Investors
& Advisors.
Mālama Labs is raising up to $5,000,000 on a post-money SAFE at a $20M valuation cap, with rolling closes. The company is pre-revenue, currently validating go-to-market through Genesis 200 Hex Node operator onboarding and pilot sensor deployments.
This page is for informational purposes only and does not constitute an offer to sell or solicitation to buy any security. Participation is available only to accredited investors where applicable. All financial projections are internal operating plan estimates, not audited figures. Consult qualified legal, tax, and financial advisors before making any investment decision.
Key Terms
Eligible investors may receive a separate token side letter providing contingent participation rights in a future designated Mālama network token (MLMA), if and when launched. Subject to applicable law, completion of Beneficial Technology Howey test analysis, compliance procedures, vesting, lockups, transfer restrictions, and final launch structure. This is not a present token sale and confers no current rights to MLMA. Regulatory classification of MLMA is subject to ongoing legal review.
Rolling closes. Pro-rata rights reserved for seed investors. Three-to-five year target hold period. Series A trigger: 20+ live projects with recurring MRV revenue.
Scheduled emissions stop after Year 3.
Mālama's MLMA model uses token issuance only as a limited bootstrap mechanism. Scheduled emissions are constrained to the cold-start period and end entirely after Year 3. Years 4 and 5 are modeled as revenue-funded, not emission-funded. Many DePIN protocols depend indefinitely on inflation. Mālama is designed not to.
The 500M MLMA hard cap is enforced on-chain. Emergency issuance beyond this cap is not a governance option — it would require a new smart contract deployment and separate investor consent. This is a deliberate design choice to make the model legible and stress-testable for institutional readers.
Year 5 revenue by stream (confirmed operating model).
The table below reflects the confirmed 5-stream + MRAA-01 revenue model. Conservative case assumes 40% of addressable volume. Base case assumes 60–70%. All figures in USD. Internal operating plan, not an audited projection.
All revenue projections are internal estimates based on modeled assumptions about market penetration, product deployment, and pricing. Actual results may differ materially. The company is pre-revenue as of April 2026.
Where the capital deploys.
Request access.
All materials are provided under NDA or by direct request. Use the forms below or email tyler@malamalabs.com directly.
dMRV Whitepaper
Full six-layer architecture, three-chain coordination (Cardano, Hedera, Base), H3 reward scaling, tokenomics, revenue model, and regulatory positioning. Technical due diligence reference document.
PDF · Technical · No NDA required
Request →
Seed Investor Deck
17 slides. Market thesis, 30-year problem history, hardware-signed insight, token architecture, flywheel, traction, team, seven-market overview with deep dives, business model, and raise structure. 18–22 minute walkthrough.
PDF / Slides · Confidential · NDA on request
Request →
Full Data Room
Cap table, financial model (multi-sheet Excel), customer and pilot LOIs, technical due diligence documentation, patent filings, governance framework, and SAFE terms. Accessible under executed NDA.
Secure link · NDA required · Accredited investors only
Request →
Company One-Pager
Single-page summary for fast review. Thesis, traction, team, financial model headline, round structure, and contact. Suitable for sharing before NDA execution.
PDF · No NDA required
Request →
Seed Deck v3 · 17 slides.
Built around a single thesis: Mālama is the hardware-signed trust anchor for the physical world, and carbon is the beachhead market into a $4.7T addressable space. 18–22 minute walkthrough.
Schedule a call.
For investment conversations, partnership inquiries, or advisory interest. Tyler Malin, CEO — tyler@malamalabs.com
Request a Call
We'll follow up within 24 hours on business days.
Mālama does not provide investment, legal, tax, or financial advice. This page does not constitute an offer to sell or solicitation to buy any security. Participation available to accredited investors only where applicable.
Mālama Labs, Inc. · Investor Information · April 2026 · Pre-Revenue Stage
This page is for informational purposes only. Not an offer to sell or solicitation to buy any security. All projections are internal estimates, not audited figures. MLMA regulatory classification subject to ongoing Beneficial Technology legal review. Accredited investors only where applicable. © 2026 Mālama Labs, Inc.